Acute cerebellar dysfunction with high-dose ARA-C therapy
- 1 February 1983
- Vol. 51 (3) , 426-429
- https://doi.org/10.1002/1097-0142(19830201)51:3<426::aid-cncr2820510312>3.0.co;2-s
Abstract
The authors report a patient with clinical and morphologic evidence of acute cerebellar toxicity after receiving high-dose cytosine arabinoside (ARA-C) (3000 mg/m2/12 hours) for refractory AML. Damage of Purkinje cells and dentate nucleus was demonstrated. Reversible cerebellar toxicity has previously been noted in patients on an identical regimen. Signs of cerebellar dysfunction mandate immediate cessation of highdose ARA-C therapy.This publication has 8 references indexed in Scilit:
- Central nervous system toxicity of high-dose systemic cytosine arabinosideCancer, 1981
- High dose cytosine arabinoside (HDARAC) in refractory acute leukemiaCancer, 1979
- Paraplegia following intrathecal cytosine arabinosideCancer, 1979
- Maturation of Purkinje cells in mouse cerebellum after neonatal administrations of cytosine arabinosideActa Neuropathologica, 1978
- Paraparesis following intrathecal cytosine arabinoside.A case report with neuropathologic findingsCancer, 1977
- Pseudomembranous colitis.Journal of Clinical Pathology, 1977
- Cytarabine and Its Effect on Cerebellum of Suckling MouseArchives of Neurology, 1975
- Treatment of central nervous system leukemia with intrathecal cytosine arabinosideCancer, 1973